Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/13/2025

Management of Elevated Liver Function Tests in Post-Liver Transplant Patients

Initial Assessment and Management

  • Compliance with immunosuppression medications should be immediately assessed, as non-compliance is a common cause of rejection 1
  • Review of all medications for potential drug interactions that could affect tacrolimus levels is necessary 1
  • Consider adding or optimizing mycophenolate mofetil if rejection is suspected or confirmed 1
  • Administer high-dose corticosteroids (methylprednisolone) if acute cellular rejection is confirmed 1
  • Optimize tacrolimus dosing to achieve higher target trough levels temporarily if acute cellular rejection is confirmed 1
  • Consider adding a second immunosuppressive agent if not already present 1
  • For patients with confirmed rejection who are steroid-refractory, consider consultation with transplant hepatology for potential adjustment of immunosuppression regimen 1

Lifestyle Modifications and Metabolic Management

  • Implement lifestyle modifications including diet and physical activity if metabolic syndrome or recurrent/de novo MASH is suspected 2
  • Consider adjusting immunosuppression regimen in consultation with transplant team if metabolic syndrome or recurrent/de novo MASH is suspected 2
  • Aggressively manage metabolic complications (hypertension, dyslipidemia, diabetes) 2, 3
  • Management of metabolic complications should include lifestyle modifications and pharmacological treatment 2, 3

REFERENCES